Biotech

All Articles

I &amp I biotech Triveni increases $115M for preclinical antitoxins

.Triveni Bio has actually roped in $115 thousand in set B funds to advance preclinical antibody plan...

IGM turns from cancer to autoimmune, agitating C-suite

.IGM Biosciences finished in 2014 giving up workers and also simplifying its own cancer pipe. Right ...

Shattuck centers CD47 system over weak efficiency information, gives up 40% of workers and drops Ono handle

.Shattuck Labs has actually knocked one more nail in to the coffin of CD47. After seeing a "reasonab...

BioMarin goes Camping outdoors, striking RNA handle biotech

.BioMarin is incorporating combustion to the R&ampD fire, blowing a match along with CAMP4 Therapeut...

Cash- strapped Gritstone starts look for strategic substitutes as cancer cells vaccine records underwhelm

.Gritstone bio has actually produced banks to look into "prospective value-maximizing tactics" after...

Kailera launches along with $400M set A, 4 Chinese excessive weight medicines

.Kailera Therapeutics has released in to the progressively crowded obesity space with a portfolio of...

Metsera associate with Amneal to latch down GLP-1 supply

.Along with early phase 1 data now out in the wild, metabolic disease ensemble Metsera is wasting no...

Rivus articles data to support muscle-sparing obesity medication cases

.Rivus Pharmaceuticals has actually introduced the information behind its stage 2 being overweight g...

BMS spends $110M to create T-cell therapy contract, helping Prime buy opportunity to develop prioritized pipe

.Bristol Myers Squibb is paying out Prime Medication $110 thousand upfront to create reagents for ex...

Generate gains an additional $1B-plus Big Pharma relationship

.Novartis has tattooed a package potentially worth much more than $1 billion along with Flagship-fou...